Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
04/27/2010
Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease Week
03/31/2010
Lexicon Pharmaceuticals Announces Webcast of 2010 Annual R&D Day
03/19/2010
Lexicon Pharmaceuticals 2009 Annual Report to Stockholders Available Online
03/19/2010
Lexicon Announces Completion of Common Stock Offering
03/16/2010
Lexicon Announces Pricing of Common Stock in Public Offering
03/07/2010
Lexicon Announces Proposed $95 Million Common Stock Offering
02/23/2010
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2009 Fourth Quarter And Full Year Financial Results
02/16/2010
Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010
02/03/2010
Lexicon Pharmaceuticals to present at the 12th Annual BIO CEO & Investor Conference
01/26/2010
Lexicon to host conference call and webcast to review top-line phase 2 results from diabetes trial
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 2 of 37
